Cargando…

Structure-Based Design of Potent and Selective Ligands at the Four Adenosine Receptors

The four receptors that signal for adenosine, A(1), A(2A), A(2B) and A(3) ARs, belong to the superfamily of G protein-coupled receptors (GPCRs). They mediate a number of (patho)physiological functions and have attracted the interest of the biopharmaceutical sector for decades as potential drug targe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jespers, Willem, Oliveira, Ana, Prieto-Díaz, Rubén, Majellaro, María, Åqvist, Johan, Sotelo, Eddy, Gutiérrez-de-Terán, Hugo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6150288/ https://www.ncbi.nlm.nih.gov/pubmed/29125553 http://dx.doi.org/10.3390/molecules22111945

Ejemplares similares

Identification of V6.51L as a selectivity hotspot in stereoselective A(2B) adenosine receptor antagonist recognition
por: Wang, Xuesong, et al.
Publicado: (2021)

Deciphering conformational selectivity in the A(2A) adenosine G protein-coupled receptor by free energy simulations
por: Jespers, Willem, et al.
Publicado: (2021)

Free-Energy Calculations for Bioisosteric Modifications of A(3) Adenosine Receptor Antagonists
por: Jandova, Zuzana, et al.
Publicado: (2019)

X‐Ray Crystallography and Free Energy Calculations Reveal the Binding Mechanism of A(2A) Adenosine Receptor Antagonists
por: Jespers, Willem, et al.
Publicado: (2020)

A(2B) adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models
por: Tay, Apple Hui Min, et al.
Publicado: (2022)

Potent and Subtype-Selective Dopamine D(2) Receptor Biased Partial Agonists Discovered via an Ugi-Based Approach
por: Mallo-Abreu, Ana, et al.
Publicado: (2021)

QligFEP: an automated workflow for small molecule free energy calculations in Q
por: Jespers, Willem, et al.
Publicado: (2019)

Exploring the Effect of Halogenation in a Series of Potent and Selective A(2B) Adenosine Receptor Antagonists
por: Prieto-Díaz, Rubén, et al.
Publicado: (2022)

Structural and Energetic Effects of A(2A) Adenosine Receptor Mutations on Agonist and Antagonist Binding
por: Keränen, Henrik, et al.
Publicado: (2014)

Exploring Non-orthosteric Interactions with a Series of Potent and Selective A(3) Antagonists
por: Miranda-Pastoriza, Darío, et al.
Publicado: (2022)

Computational Prediction of Alanine Scanning and Ligand Binding Energetics in G-Protein Coupled Receptors
por: Boukharta, Lars, et al.
Publicado: (2014)

Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A(1) Antagonists
por: Val, Cristina, et al.
Publicado: (2022)

The GPR139 reference agonists 1a and 7c, and tryptophan and phenylalanine share a common binding site
por: Nøhr, Anne Cathrine, et al.
Publicado: (2017)

Special Issue: Adenosine Receptors
por: Ciruela, Francisco, et al.
Publicado: (2017)

Evolutionary design of selective adenosine receptor ligands
por: van der Eelke, Horst, et al.
Publicado: (2010)

Structural Basis of Inhibition of Human Insulin-Regulated Aminopeptidase (IRAP) by Benzopyran-Based Inhibitors
por: Vanga, Sudarsana Reddy, et al.
Publicado: (2021)

Fluorescence based HTS-compatible ligand binding assays for dopamine D(3) receptors in baculovirus preparations and live cells
por: Tahk, Maris-Johanna, et al.
Publicado: (2023)

Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists
por: Vasile, Silvana, et al.
Publicado: (2020)

Cancer-Associated Mutations of the Adenosine A(2A) Receptor Have Diverse Influences on Ligand Binding and Receptor Functions
por: Feng, Chenlin, et al.
Publicado: (2022)

Author Correction: Inhibition of translation termination by small molecules targeting ribosomal release factors
por: Ge, Xueliang, et al.
Publicado: (2020)

Inhibition of translation termination by small molecules targeting ribosomal release factors
por: Ge, Xueliang, et al.
Publicado: (2019)

Calculation of Heat Capacity Changes in Enzyme Catalysis and Ligand Binding
por: Åqvist, Johan, et al.
Publicado: (2022)

Development of Fluorescent 4-[4-(3H-Spiro[isobenzofuran-1,4′-piperidin]-1′-yl)butyl]indolyl Derivatives as High-Affinity Probes to Enable the Study of σ Receptors via Fluorescence-Based Techniques
por: Abatematteo, Francesca Serena, et al.
Publicado: (2023)

Functional selectivity of adenosine receptor ligands
por: Verzijl, Dennis, et al.
Publicado: (2011)

Potent Inhibition of Nicotinamide N-Methyltransferase by Alkene-Linked Bisubstrate Mimics Bearing Electron Deficient Aromatics
por: Gao, Yongzhi, et al.
Publicado: (2021)

Structure-Guided Drug Design of 6-Substituted Adenosine Analogues as Potent Inhibitors of Mycobacterium tuberculosis Adenosine Kinase
por: Crespo, Roberto A., et al.
Publicado: (2019)

Structural Basis of Inhibition of Human Insulin-Regulated Aminopeptidase (IRAP) by Aryl Sulfonamides
por: Vanga, Sudarsana Reddy, et al.
Publicado: (2018)

A Series of Analogues to the AT(2)R Prototype Antagonist C38 Allow Fine Tuning of the Previously Reported Antagonist Binding Mode
por: Isaksson, Rebecka, et al.
Publicado: (2019)

Cancer-Related Somatic Mutations in Transmembrane Helices Alter Adenosine A1 Receptor Pharmacology
por: Wang, Xuesong, et al.
Publicado: (2022)

Design and Synthesis of Conformationally Flexible Scaffold as Bitopic Ligands for Potent D(3)-Selective Antagonists
por: Kim, Ho Young, et al.
Publicado: (2022)

Synthesis of adenosine analogues with indole moiety as human adenosine A(3) receptor ligands
por: Xia, Yan, et al.
Publicado: (2018)

Identification of Potent and Selective JAK1 Lead Compounds Through Ligand-Based Drug Design Approaches
por: Babu, Sathya, et al.
Publicado: (2022)

Origin of the omnipotence of eukaryotic release factor 1
por: Lind, Christoffer, et al.
Publicado: (2017)

Novel Cephalosporin Conjugates Display Potent and Selective Inhibition of Imipenemase-Type Metallo-β-Lactamases
por: Tehrani, Kamaleddin H. M. E., et al.
Publicado: (2021)

Synthesis, Evaluation and Proposed Binding Pose of Substituted Spiro‐Oxindole Dihydroquinazolinones as IRAP Inhibitors
por: Engen, Karin, et al.
Publicado: (2020)

Adenosine Analog NITD008 Is a Potent Inhibitor of Zika Virus
por: Deng, Yong-Qiang, et al.
Publicado: (2016)

Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: Effect of the N-5 bond type on the affinity and selectivity at the four adenosine receptor subtypes
por: Bolcato, Chiara, et al.
Publicado: (2007)

Principles of tRNA(Ala) Selection by Alanyl–tRNA Synthetase Based on the Critical G3·U70 Base Pair
por: Kumar, Amit, et al.
Publicado: (2019)

Pyrazolo Derivatives as Potent Adenosine Receptor Antagonists: An Overview on the Structure-Activity Relationships
por: Cheong, Siew Lee, et al.
Publicado: (2011)

Multicomponent Reaction-Assisted Drug Discovery: A Time- and Cost-Effective Green Approach Speeding Up Identification and Optimization of Anticancer Drugs
por: Graziano, Giovanni, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o35mpms22hf3ton43k316n0der